RL
Therapeutic Areas
Biodesix Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Nodify Lung® Tests (XL2 & CDT) | Risk assessment of indeterminate pulmonary nodules | Commercial |
| GeneStrat® (ddPCR & NGS) | Detection of actionable genomic alterations in advanced lung cancer | Commercial |
| VeriStrat® | Prognostic assessment in lung cancer | Commercial |
| Drug Candidate 1 | Oncology (Likely Lung Cancer) | Undisclosed Preclinical/Discovery |
| Drug Candidate 2 | Oncology (Likely Lung Cancer) | Undisclosed Preclinical/Discovery |
| Drug Candidate 3 | Oncology (Likely Lung Cancer) | Undisclosed Preclinical/Discovery |